{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:50Z","timestamp":1790393630728,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Acute ischemic stroke patients are at risk of acute kidney injury due to volume depletion, contrast exposure, and preexisting comorbid diseases. We determined the occurrence rate and identified predictors associated with acute kidney injury in acute ischemic stroke patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Multiple specialized ICUs within academic medical centers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Post hoc analysis of pooled data from prospective randomized clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Acute ischemic stroke patients recruited within 3 hours or within 5 hours of symptom onset.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>IV recombinant tissue plasminogen activator, endovascular treatment, IV albumin, or placebo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Serum creatinine levels from baseline and within day 5 or discharge were used to classify acute kidney injury classification into stages. Any increase in serum creatinine was seen in 697 (36.1%) and acute kidney injury was seen in 68 (3.5%) of 1,931 patients with acute ischemic stroke. Severity of acute kidney injury was grade I, II, and III in 3.1%, 0.4%, and 0.05% patients, respectively. Patients with albumin (5.5% compared with 2.6%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001), preexisting hypertension (4.3% compared with 1.5%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0041), and preexisting renal disease (9.1% compared with 3.0%; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) had higher risk of acute kidney injury. The risk of acute kidney injury was lower between those who either underwent CT angiography (2.0% compared with 4.7%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0017) or endovascular treatment (1.6% compared with 4.2%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0071). In the multivariate analysis, hypertension (odds ratio, 2.6; 95% CI, 1.2\u20135.6) and renal disease (odds ratio, 3.5; 95% CI, 1.9\u20136.5) were associated with acute kidney injury. The risk of death was significantly higher among patients with acute kidney injury (odds ratio, 2.7; 95% CI, 1.4\u20134.9) after adjusting for age and National Institutes of Health Stroke Scale score strata.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The occurrence rate of acute kidney injury in acute ischemic stroke patients was low and was not higher in patients who underwent CT angiogram or those who received endovascular treatment. Occurrence of acute kidney injury increased the risk of death within 3 months among acute ischemic stroke patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004464","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:00:28Z","timestamp":1593543628000},"page":"1334-1339","source":"Crossref","is-referenced-by-count":37,"title":["Acute Kidney Injury in Acute Ischemic Stroke Patients in Clinical Trials"],"prefix":"10.1097","volume":"48","author":[{"given":"Adnan I.","family":"Qureshi","sequence":"first","affiliation":[{"name":"Department of Neurology, Zeenat Qureshi Stroke Institute, St. Cloud, MN."},{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunain","family":"Aslam","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zeenat Qureshi Stroke Institute, St. Cloud, MN."},{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werdah","family":"Zafar","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zeenat Qureshi Stroke Institute, St. Cloud, MN."},{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zeenat Qureshi Stroke Institute, St. Cloud, MN."},{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Lobanova","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zeenat Qureshi Stroke Institute, St. Cloud, MN."},{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed H.","family":"Naqvi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar N.","family":"Chandrasekaran","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Siddiq","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi R.","family":"French","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo R.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Missouri, Columbia, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12882-018-1085-0","article-title":"Incidence and impact on outcomes of acute kidney injury after a stroke: A systematic review and meta-analysis.","volume":"19","author":"Arnold","year":"2018","journal-title":"BMC Nephrol"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000479338","article-title":"Acute kidney injury following acute ischemic stroke and intracerebral hemorrhage: A meta-analysis of prevalence rate and mortality risk.","volume":"45","author":"Zorrilla-Vaca","year":"2018","journal-title":"Cerebrovasc Dis"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12028-008-9169-5","article-title":"The hydration influence on the risk of stroke (THIRST) study.","volume":"10","author":"Rodriguez","year":"2009","journal-title":"Neurocrit Care"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/01.STR.31.9.2043","article-title":"Influence of raised plasma osmolality on clinical outcome after acute stroke.","volume":"31","author":"Bhalla","year":"2000","journal-title":"Stroke"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.02.027","article-title":"Renal safety of intra-arterial treatment after acute ischemic stroke with multimodal CT imaging selection.","volume":"28","author":"Hu","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R6-20230728","first-page":"652","article-title":"Risk of acute kidney injury with consecutive, multidose use of iodinated contrast in patients with acute ischemic stroke.","volume":"40","author":"Jia","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000499029","article-title":"Incidence, risk factors, and biomarkers predicting ischemic or hemorrhagic stroke associated acute kidney injury and outcome: A retrospective study in a general intensive care unit.","volume":"47","author":"Jiang","year":"2019","journal-title":"Blood Purif"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/STROKEAHA.114.004672","article-title":"Acute renal failure is associated with higher death and disability in patients with acute ischemic stroke: Analysis of nationwide inpatient sample.","volume":"45","author":"Saeed","year":"2014","journal-title":"Stroke"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"e0185589","DOI":"10.1371\/journal.pone.0185589","article-title":"The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis.","volume":"12","author":"Gadalean","year":"2017","journal-title":"PLoS One"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.005","article-title":"Acute kidney injury is associated with increased hospital mortality after stroke.","volume":"23","author":"Khatri","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1474-4422(13)70223-0","article-title":"High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: A randomised, double-blind, phase 3, placebo-controlled trial.","volume":"12","author":"Ginsberg","year":"2013","journal-title":"Lancet Neurol"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/STROKEAHA.110.596072","article-title":"The albumin in acute stroke (ALIAS) multicenter clinical trial: Safety analysis of part 1 and rationale and design of part 2.","volume":"42","author":"Ginsberg","year":"2011","journal-title":"Stroke"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1214300","article-title":"Endovascular therapy after intravenous t-PA versus t-PA alone for stroke.","volume":"368","author":"Broderick","year":"2013","journal-title":"N Engl J Med"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1747-4949.2008.00151.x","article-title":"Methodology of the interventional management of stroke III trial.","volume":"3","author":"Khatri","year":"2008","journal-title":"Int J Stroke"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1186\/cc6997","article-title":"Acute kidney injury in intensive care unit patients: A comparison between the RIFLE and the acute kidney injury network classifications.","volume":"12","author":"Lopes","year":"2008","journal-title":"Crit Care"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1161\/STROKEAHA.109.557256","article-title":"Reliability of the modified Rankin Scale: A systematic review.","volume":"40","author":"Quinn","year":"2009","journal-title":"Stroke"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/MD.0000000000000286","article-title":"Renal dysfunction and thrombolytic therapy in patients with acute ischemic stroke: A systematic review and meta-analysis.","volume":"93","author":"Hao","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/STROKEAHA.117.017808","article-title":"Influence of renal impairment on outcome for thrombolysis-treated acute ischemic stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) post hoc analysis.","volume":"48","author":"Carr","year":"2017","journal-title":"Stroke"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1161\/STROKEAHA.119.026738","article-title":"Contrast-associated acute kidney injury in endovascular thrombectomy patients with and without baseline renal impairment.","volume":"50","author":"Diprose","year":"2019","journal-title":"Stroke"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/ndt\/gfm591","article-title":"The impact of acute kidney injury on short-term survival in an Eastern European population with stroke.","volume":"23","author":"Covic","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3174\/ajnr.A1257","article-title":"Renal safety of CT angiography and perfusion imaging in the emergency evaluation of acute stroke.","volume":"29","author":"Hopyan","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/STROKEAHA.107.482778","article-title":"Incidence of radiocontrast nephropathy in patients undergoing acute stroke computed tomography angiography.","volume":"38","author":"Krol","year":"2007","journal-title":"Stroke"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jvir.2016.05.031","article-title":"Medicare utilization of CT angiography from 2001 through 2014: Continued growth by radiologists.","volume":"27","author":"Prabhakar","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ajem.2017.12.057","article-title":"Increasing utilization of emergency department neuroimaging in Medicare beneficiaries from 1994 to 2015.","volume":"36","author":"Prabhakar","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1161\/STROKEAHA.112.658781","article-title":"National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era.","volume":"43","author":"Hassan","year":"2012","journal-title":"Stroke"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1161\/STROKEAHA.119.025112","article-title":"Endovascular stroke therapy trends from 2011 to 2017 show significant improvement in clinical and economic outcomes.","volume":"50","author":"Rai","year":"2019","journal-title":"Stroke"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/neurintsurg-2019-015019","article-title":"National trends in endovascular therapy for acute ischemic stroke: Utilization and outcomes.","volume":"12","author":"Stein","year":"2020","journal-title":"J Neurointerv Surg"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/cc9308","article-title":"Hyperoncotic colloids and acute kidney injury: A meta-analysis of randomized trials.","volume":"14","author":"Wiedermann","year":"2010","journal-title":"Crit Care"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13741-018-0110-y","article-title":"Acute kidney injury in postoperative shock: Is hyperoncotic albumin administration an unrecognized resuscitation risk factor?.","volume":"7","author":"Udeh","year":"2018","journal-title":"Perioper Med (Lond)"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1007\/s00134-008-1226-1","article-title":"Hyperoncotic colloids in shock and risk of renal injury: Enough evidence for a banning order?.","volume":"34","author":"Honore","year":"2008","journal-title":"Intensive Care Med"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0272-6386(12)80040-0","article-title":"Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator.","volume":"21","author":"Gupta","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-111-8-687","article-title":"Tissue plasminogen activator and cholesterol crystal embolization.","volume":"111","author":"Bhardwaj","year":"1989","journal-title":"Ann Intern Med"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccc.2015.06.001","article-title":"Diagnostic criteria for acute kidney injury: Present and future.","volume":"31","author":"Kellum","year":"2015","journal-title":"Crit Care Clin"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ajkd.2015.12.033","article-title":"Clinical use of the urine biomarker [TIMP-2] \u00d7 [IGFBP7] for acute kidney injury risk assessment.","volume":"68","author":"Vijayan","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","article-title":"Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study.","volume":"267","author":"G\u00f6cze","year":"2018","journal-title":"Ann Surg"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","article-title":"Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial.","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T11:47:55Z","timestamp":1690544875000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004464","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}